Dr. Kiminobu Sugaya
My Social Links

Dr. Kiminobu Sugaya

Professor
University of Central Florida, Florida

Highest Degree
PostDoc Fellow in Pharmacology from Mayo Clinic Jacksonville, USA

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Neuropharmacology
62%
Molecular Biology
90%
Neurobiology
75%
Stem Cell
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Mulberry, G., K.A. White, M. Vaidya, K. Sugaya and B.N. Kim, 2017. 3D printing and milling a real- time PCR device for infectious disease diagnostics. PLoS One, Vol. 12. 10.1371/journal.pone.0179133.
    CrossRef  |  
  2. Constant, C., A. Bergano, K. Sugaya and A. Dogariu, 2017. Guiding cellular activity with polarized light. J. Biophotonics. 10.1002/jbio.201600326.
    CrossRef  |  Direct Link  |  
  3. Khorgami, Z. and K. Sugaya, 2015. Sleep pattern: Preventing factors for Alzheimer disease. Br. J. Med. Med. Res., 9: 1-12.
  4. Gaut, C. and K. Sugaya, 2015. Critical review on the physical and mechanical factors involved in tissue engineering of cartilage. Regen. Med., 10: 665-679.
    CrossRef  |  Direct Link  |  
  5. Alvarez, A.A., M. Field, S. Bushnev, M.S. Longo and K. Sugaya, 2015. The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells. J. Mol. Neurosci., 55: 7-20.
    CrossRef  |  Direct Link  |  
  6. Valerio, L.S.A. and K. Sugaya, 2014. Potential therapeutic approaches for stroke using induced pluripotent stem cells. Austin J. Biomed. Eng., 1: 10-16.
  7. Kwak, Y.D., B.J. Hendrix and K. Sugaya, 2014. Secreted type of amyloid precursor protein induces glial differentiation by stimulating the BMP/Smad signaling pathway. Biochem. Biophys. Res. Commun., 447: 394-399.
    CrossRef  |  Direct Link  |  
  8. Kimmel, J. and K. Sugaya, 2014. Nanog overexpression increases neural marker expression in adipose derived stem cells. Recent Patent Regen. Med., 4: 69-74.
    Direct Link  |  
  9. Hendrix, B.J. and K. Sugaya, 2014. The future of neuroregenerative therapy for Parkinson’s disease. Curr. Tissue Eng., 3: 25-33.
    Direct Link  |  
  10. Sugaya, K., 2013. Anti-inflammatory therapy for alzheimer’s disease from epidemiological fact to new mechanisms of action. Anti-Inflammatory Anti-Allergy Agents Med. Chem., 9: 189-196.
    Direct Link  |  
  11. Sugaya, K., R.B. Timmons and T. Patch, 2012. Use of peripheral blood stem cells in tissue engineering. Curr. Tissue Eng., 1: 63-74.
    Direct Link  |  
  12. Sugaya, K., M.B. Youdim, A. Nordberg and K.S. Rao, 2012. Neuroprotection and neuroregeneration in Alzheimer's disease. Int. J. Alzheimers Dis., Vol. 2012. 10.1155/2012/864138.
    CrossRef  |  Direct Link  |  
  13. Keilani, S., D. Healey and K. Sugaya, 2012. Reelin regulates differentiation of neural stem cells by activation of notch signaling through Disabled-1 tyrosine phosphorylation. Can. J. Physiol. Pharmacol., 90: 361-369.
    CrossRef  |  Direct Link  |  
  14. Kwak, Y.D., E. Dantuma, S. Merchant, S. Bushnev and K. Sugaya, 2011. Amyloid-β precursor protein induces glial differentiation of neural progenitor cells by activation of the IL-6/gp130 signaling pathway. Neurotoxicity Res., 18: 328-338.
    CrossRef  |  Direct Link  |  
  15. Kwak, Y.D., A. Marutle, E. Dantuma, S. Merchant, S. Bushnev and K. Sugaya, 2011. Involvement of notch signaling pathway in amyloid precursor protein induced glial differentiation. Eur. J. Pharmacol., 650: 18-27.
    CrossRef  |  Direct Link  |  
  16. Hossain, F. and K. Sugaya, 2011. DNA Demethylation of Human Mesenchymal Stem Cells Has Increased Potential to Become Neuronal Cells. In: Human Mesenchymal and Embryonic Stem Cells, Koka, P.S. (Ed.). Nova Science Publishers, USA., ISBN: 978-1-62081-909-8, pp: 97-108.
  17. Sugaya, K., 2010. Stem cell biology in the study of pathological conditions. Neurodegenerative Dis., 7: 84-87.
    CrossRef  |  Direct Link  |  
  18. Merchant, S., E. Dantuma and K. Sugaya, 2010. A heterocyclic pyrrolopyrimidine compound as a possible candidate for topical application to induce hair restoration. Adv. Stud. Biol., 2: 63-71.
  19. Field, M., A. Alvarez, S. Bushnev and K. Sugaya, 2010. Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Clin. Neurosurg., 57: 151-159.
  20. Dantuma, E., S. Merchant and K. Sugaya, 2010. Stem cells for the treatment of neurodegenerative diseases. Stem Cell Res. Ther., Vol. 1. 10.1186/scrt37.
    CrossRef  |  Direct Link  |  
  21. Chigurupati, S., R. Venkataraman, D. Barrera, A. Naganathan and M. Madan et al., 2010. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res., 70: 418-427.
  22. Alvarez, A., M. Hossain, E. Dantuma, S. Merchant and K. Sugaya, 2010. Nanog overexpression allows human mesenchymal stem cells to differentiate into neural cells-Nanog transdifferentiates mesenchymal stem cells. Neurosci. Med., 1: 1-13.
    CrossRef  |  Direct Link  |  
  23. Vrotsos, E.G., P.E. Kolattukudy and K. Sugaya, 2009. MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling. Brain Res. Bull., 79: 97-103.
    CrossRef  |  Direct Link  |  
  24. Vrotsos, E.G. and K. Sugaya, 2009. MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling. Cell Mol. Neurobiol., 29: 373-381.
    CrossRef  |  Direct Link  |  
  25. Field, M., S. Bushnev, A.A. Alvarez, N. Avgeropoulos and K. Sugaya, 2009. Markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Neurosurgery, 65: 426-426.
  26. Biener, G., E. Vrotsos, K. Sugaya and A. Dogariu, 2009. Optical torques guiding cell motility. Opt. Express, 17: 9724-9732.
  27. Sugaya, K., 2008. Mechanism of glial differentiation of neural progenitor cells by amyloid precursor protein. Neurodegenerative Dis., 5: 170-172.
    CrossRef  |  Direct Link  |  
  28. Sugaya, K. and S. Merchant, 2008. How to approach Alzheimer's disease therapy using stem cell technologies. J. Alzheimers Dis., 15: 241-254.
    CrossRef  |  Direct Link  |  
  29. Liu, D., K.A. Hua and K. Sugaya, 2008. A generic framework for internet-based interactive applications of high-resolution 3-D medical image data. IEEE Trans. Inform. Technol. Biomed., 12: 618-626.
  30. Keilani, S. and K. Sugaya, 2008. Reelin induces a radial glial phenotype in human neural progenitor cells by activation of Notch-1. BMC Dev. Biol., Vol. 8. 10.1186/1471-213X-8-69.
    CrossRef  |  Direct Link  |  
  31. Hossain, F. and K. Sugaya, 2008. DNA demethylation of human mesenchymal stem cells has increased potential of become neuronal cells. J. Stem Cells, 3: 173-182.
  32. Sugaya, K., Y.D. Kwak, O. Ohmitsu, A. Marutle, N.H. Greig and E. Choumrina, 2007. Practical issues in stem cell therapy for Alzheimer's disease. Curr. Alzheimer Res., 4: 370-377.
  33. Pulido, J.S., I. Sugaya, J. Comstock and K. Sugaya, 2007. Reelin expression is upregulated following ocular tissue injury. Graefes Arch. Clin. Exp. Ophthalmol., 245: 889-893.
    CrossRef  |  Direct Link  |  
  34. Marutle, A., M. Ohmitsu, N. Nilbratt, N.H. Greig, A. Nordberg and K. Sugaya, 2007. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proc. Natl. Acad. Sci. USA., 104: 12506-12511.
    CrossRef  |  Direct Link  |  
  35. Sugaya, K., A. Alvarez, A. Marutle and Y.D. Kwak, 2006. Choumkina E: Stem cell strategies for Alzheimer's disease therapy. Panminerva Med., 48: 87-96.
  36. Sugaya, I., T. Qu, K. Sugaya and G.D. Pappas, 2006. Genetically enginieered human mesenchymal stem cells produce Met-Enkephalin at augmented higher levels in vitro. Cell Transplant., 15: 225-230.
  37. Roitberg, B.Z., E. Mangubat, E.Y. Chen, K. Sugaya and K.R. Thulborn et al., 2006. Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J. Neurosurg., 105: 96-102.
    CrossRef  |  Direct Link  |  
  38. Kwak, Y.D., E. Choumkina and K. Sugaya, 2006. Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells. Biochem. Biophys. Res. Commun., 344: 431-437.
    CrossRef  |  Direct Link  |  
  39. Kwak, Y.D., C.L. Brannen, T. Qu, H.M. Kim and X. Dong et al., 2006. Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev., 15: 381-389.
    CrossRef  |  Direct Link  |  
  40. Kwak, Y.D. and K. Sugaya, 2006. RNA interference in human NTera-2/D1 cell lines using human U6 promoter-based siRNA PCR products. Biotechnol. Bioprocess Eng., 3: 273-276.
  41. Sugaya, K., 2005. Stem Cell Strategies for Alzheimer’s Disease. In: Recent Progress in Alzheimer’s and Parkinson’s Diseases, Hanin, I., R. Cacabelos and A. Fisher (Eds.). Taylor and Francis Inc., New York, pp: 183-190.
  42. Sugaya, K., 2005. Possible use of autologous stem cell therapies for Alzheimer`s disease. Curr. Alzheimer Res., 2: 367-376.
  43. Qu, T., X. Dong, I. Sugaya, A. Vaghani, J. Pulido and K. Sugaya, 2004. Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. Restor. Neurol. Neurosci., 22: 459-468.
  44. Sugaya, K., 2003. Stem cell strategies, future and beyond. Seishin Shinkeikagaku Zasshi, 105: 68-80.
  45. Sugaya, K., 2003. Stem cell biology under pathological condition. J. Cell. Mol. Life Sci., 60: 1891-1902.
  46. Sugaya, K., 2003. Stem Cell Therapy for Alzheimer’s Disease. In: Alzheimer's Disease-The Basics: A Physician's Guide to the Practical Management, Richter, R.W. and B. Richter (Eds.). Humana Press, New York, pp: 289-300.
  47. Sugaya, K., 2003. Research strategy for understanding neuronal plasticity and degeneration. Psychiatrica et Neurologica Japonica, 105: 43-46.
  48. Sugaya, K., 2003. Potential use of stem cells in neuroreplacement therapies for neurodegenerative disease. Int. Rev. Cytol., 228: 1-23.
  49. Sugaya, K., 2003. Neurodevelopment hypothesis of schizophrenia and genes. Schizophrenia Front., 4: 32-36.
  50. Sugaya, K., 2003. Current topics in stem cell research. Pharmacia, 39: 103-107.
  51. Kwak, Y.D., H. Koike and K. Sugaya, 2003. RNA interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector. J. Pharmacol. Sci., 93: 214-217.
    CrossRef  |  Direct Link  |  
  52. Dong, X., J. Pulido and K. Sugaya, 2003. Differentiation of human neural stem cells into retinal cells. NeuroReport, 14: 143-146.
  53. Uz, T., T. Qu, K. Sugaya and H. Manev, 2002. Neuronal expression of arylalkylamine N-acetyltransferase (AANAT) mRNA in the rat brain. Neurosci. Res., 42: 309-316.
    CrossRef  |  Direct Link  |  
  54. Sugaya, K., T. Qu, C. Brannen and M. Kim, 2002. Human Neural Stem Cell Transplantation Improves Cognitive Function in Aged Rats. In: Mapping the Progress of Alzheimer’s and Parkinson’s Disease, Mizuno, Y., A. Fisher and I. Hanin (Eds.). Springer, New York, ISBN: 9780306467639, pp: 229-234.
  55. Kim, H.M., T. Qu, V. Kriho, P. Lacor and N. Smalheiser et al., 2002. Reelin function in neural stem cell biology. Proc. Nat. Acad. Sci., 99: 4020-4025.
    CrossRef  |  Direct Link  |  
  56. Sugaya, K., T. Uz, V. Kumar and H. Manev, 2001. New anti-inflammatory treatment strategy in Alzheimer's disease. Japanese J. Pharmacol., 82: 85-94.
    CrossRef  |  
  57. Sugaya, K., 2001. Human neural stem cell transplantation as a future therapy for neurodegenerative disease. Brain Sci., 23: 882-884.
  58. Sugaya, K., 2001. Glial activation in aging and its pathological implication. Folia Pharmacol. Japonica, 118: 251-257.
  59. Sugaya, K. and C.L. Brannen, 2001. Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med. Hypotheses, 57: 697-700.
    CrossRef  |  Direct Link  |  
  60. Qu, T., C.L. Brannen, H.M. Kim and K. Sugaya, 2001. Human neural stem cells improve cognitive function of aged brain. Neuroreport, 12: 1127-1132.
    Direct Link  |  
  61. Nicolle, M.M., J. Gonzalez, K. Sugaya, K.A. Baskerville and D. Bryan et al., 2001. Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience, 107: 415-431.
    CrossRef  |  Direct Link  |  
  62. Hernandez, D., K. Sugaya, T. Qu, E. McGowan, K. Duff and M. McKinney, 2001. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes. Neuroreport, 12: 1377-1384.
    Direct Link  |  
  63. Manev, H., T. Uz, K. Sugaya and T. Qu, 2000. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J., 14: 1464-1469.
    CrossRef  |  
  64. Fass, U., K. Panickar, D. Personett, D. Bryan and K. Williams et al., 2000. Differential vulnerability of primary cultured cholinergic neurons to nitric oxide excess. Neuroreport, 11: 931-936.
    Direct Link  |  
  65. Brannen, C.L. and K. Sugaya, 2000. In vitro differentiation of multipotent human neural progenitors in serum‐free medium. Neuroreport, 11: 1123-1128.
  66. Kent, C., K. Sugaya, D. Bryan, D. Personett and M. McKinney, 1999. Expression of superoxide dismutase messenger RNA in adult rat brain cholinergic neurons. J. Mol. Neurosci., 12: 1-10.
    Direct Link  |  
  67. Sugaya, K., S. Chou, S.J. Xu and M. McKinney, 1998. Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin. Mol. Brain Res., 58: 1-9.
    CrossRef  |  Direct Link  |  
  68. Sugaya, K., R. Greene, D. Personett, M. Robbins and C. Kent et al., 1998. Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline. Neurobiol. Aging, 19: 351-361.
    CrossRef  |  Direct Link  |  
  69. Sugaya, K., M.L. Chouinard and M. McKinney, 1997. Induction of manganese superoxide dismutase in BV-2 microglial cells. Neuroreport, 8: 3547-3551.
    Direct Link  |  
  70. Sugaya, K., M. Reeves and M. McKinney, 1997. Topographic associations between DNA fragmentation and Alzheimer`s disease neuropathology in the hippocampus. Neurochem. Int., 31: 275-281.
    CrossRef  |  
  71. Sugaya, K., M. Chouinard and M. McKinney, 1997. Immunostimulation protects microglial cells from nitric oxide-mediated apoptosis. Neuroreport, 8: 2241-2245.
    Direct Link  |  
  72. Sugaya, K., C. Clamp, D. Bryan and M. McKinney, 1997. Messenger RNA for the m4 muscarinic receptor subtype is expressed in adult rat central cholinergic neurons. Mol. Brain Res., 50: 305-313.
  73. Personett, D., K. Sugaya, D. Hammond, M. Robbins and M. McKinney, 1997. Use of capillary electrophoresis with laser‐induced fluorescence detection to assess messenger ribonucleic acid molecules amplified by the polymerase chain reaction: Applications in the cloning of cells. Electrophoresis, 18: 1750-1759.
    CrossRef  |  Direct Link  |  
  74. Sugaya, K., M. Chouinard, R. Greene, M. Robbins and D. Personett et al., 1996. Molecular indices of neuronal and glial plasticity in the hippocampal formation in a rodent model of age-induced spatial learning impairment. J. Neurosci., 16: 3427-3443.
    Direct Link  |  
  75. Personett, D.A., M. Chouinard, K. Sugaya and M. McKinney, 1996. Simplified RT/PCR quantitation of gene transcripts in cultured neuroblastoma (SN49) and microglial (BV-2) cells using capillary electrophoresis and laser-induced fluorescence. J. Neurosci. Methods, 65: 77-91.
    CrossRef  |  
  76. Kumar, V., K. Sugaya, S. Saunders and J. Mechanic, 1996. Update on cholinergic drugs in Alzheimer's disease. Medicamentos de Actualidad, 32: 529-537.
  77. Sugaya, K., K. Matsunaga, Y. Sei and M. McKinney, 1995. Kangenkaryu, Chinese Herb Medicine, Improved Several Symptoms in the Animal Model. In: Alzheimer's and Parkinson's Diseases: Recent Advances, Hanin, I., A. Fisher and M. Yoshida (Eds.). Plenum Publishing Corporation, USA., pp: 411-419.
  78. Sugaya, K. and M. McKinney, 1994. Nitric oxide synthase gene expression in cholinergic neurons in the rat brain examined by combined immunocytochemistry and in situ hybridization histochemistry. Brain Res. Mol., 23: 111-125.
    CrossRef  |  
  79. Sugaya, K. and M. McKinney, 1994. Nitric Oxide Synthase in a Lesion Model of Alzheimer's Disease. In: Current Research in Alzheimer Therapy, Giacobini, E. and R. Becker (Eds.). Taylor and Francis, New York, pp: 304-309.
  80. Kizuki, K., T. Suzuki, K. Sugaya, T. Noguchi and M. Kudo, 1994. Tissue kallikrein in rat and mouse neurons. Braz. J. Med. Biol. Res., 27: 1891-1896.
    Direct Link  |  
  81. Takahashi, M., K. Sugaya, K. Kojima, T. Katoh, M. Ueki and K. Kubota, 1993. SUT-8701, a cholecystokinin analog, prevents the cholinergic degeneration in the rat cerebral cortex following basal forebrain lesioning. Japanese J. Pharmacol., 61: 341-349.
    CrossRef  |  
  82. Takahashi, M., K. Sugaya and K. Kubota, 1992. Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion. Japanese J. Pharmacol., 60: 307-310.
    CrossRef  |  
  83. Sugaya, K., M. Takahashi and K. Kubota, 1992. Cholecystokinin protects cholinergic neurons against basal forebrain lesion. Japanese J. Pharmacol., 59: 125-128.
    CrossRef  |  
  84. Sugaya, K., M. Downen and E. Giacobini, 1991. Nucleus basalis lesion decrease bungarotoxins binding site in rat cortex. Neuro Rep., 2: 177-180.
  85. Sugaya, K., 1991. The Effect of Kangenkaryu on the Dementia Model Animal. In: Ecology in Food, Igarashi, N. and K. Namiki (Eds.). Happy End Book, Tokyo, Japan, pp: 97-102.
  86. Sugaya, K., E. Giacobini and V.A. Chiappinelli, 1990. Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease. J. Neurosci. Res., 27: 349-359.
    CrossRef  |  Direct Link  |  
  87. Giacobini, E., R.J. Elble and K. Sugaya, 1990. Markers of Cholinergic Dysfunction in Alzheimer Disease. In: Alzheimer Disease Current Research in Early Diagnosis, Becker, R.E. and E. Giacobini (Eds.). Taylor and Francis, New York, pp: 137-156.
  88. Tang, Z.C., P. DeSarno, K. Sugaya and E. Giacobini, 1989. The effect of huperzin-A, new cholinesterase inhibitor, of the central cholinergic system of the rat. J. Neurosci. Res., 24: 276-285.
  89. Kubota, K., K. Sugaya, Y. Koizumi and M. Toda, 1989. Cholecystokinin antagonism by anthramycin, a benzodiazepine antibiotic, in the central nervous system in mice. Brain Res., 485: 62-66.
    CrossRef  |  Direct Link  |  
  90. Downen, M., K. Sugaya, S.P. Arneric and E. Giacobini, 1989. Time Course of Alteration ACh Synthesis and Release and Alpha-Bungarotoxin Binding in Rat Cortex Following Ibotenic Acid Lesion of the Basal Forebrain. In: Novel Approaches to the Treatment of Alzheimer's Disease, Meyer, E.M., J.W. Impkins and J. Yamamoto (Eds.). Plenum Press, New York, pp: 255-268.
  91. Sugaya, K., M.O. Maimets and K. Kubota, 1988. 2-deoxy-D-(14C)-glucose study of the interaction of caerulein and apomorphine. Japanese J. Pharmacol., 48: 131-136.
    CrossRef  |  
  92. Sugaya, K. and K. Kubota, 1988. Autoradiographic demonstration of the antagonism of anthramycin and diazepam against cholecystokinin in the mouse brain using the [14C]-2-deoxyglucose method. Japanese J. Pharmacol., 48: 1-6.
    CrossRef  |  
  93. Kubota, K., K. Sugaya and K. Hotta, 1988. Effects of cimetidine on prostanoid production in the gastric corpus specimens from rats. Japanese J. Pharmacol., 48: 491-493.
  94. Sugaya, K., I. Matsuda and K. Kubota, 1987. Possible involvement of the CCK receptor in the benzodiazepine antagonism to CCK in the mouse brain. Japanese J. Pharmacol., 43: 67-71.
    CrossRef  |  
  95. Kubota, K., I. Matsuda, K. Sugaya and T. Uruno, 1986. Cholecystokinin antagonism by benzodiazepines in the food intake in mice. Physiol. Behav., 36: 175-178.
    CrossRef  |  Direct Link  |  
  96. Kubota, K., F. Sun, K. Sugaya and N. Sunagane, 1986. Reversal of antinociceptive effect of caerulein by benzodiazepine. J. Pharm. Dynamics, 9: 428-431.
    CrossRef  |  
  97. Sugaya, K., I. Matsuda and K. Kubota, 1985. Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice. Japanese J. Pharmacol., 39: 277-280.
    CrossRef  |  
  98. Kubota, K., K. Sugaya, N. Sunagane, I. Matsuda and T. Uruno, 1985. Cholecystokinin antagonism by benzodiazepines in the contractile response of the isolated guinea-pig gallbladder. Eur. J. Pharmacol., 110: 225-231.
    CrossRef  |  Direct Link  |  
  99. Kubota, K., K. Sugaya, I. Matsuda, Y. Matsuoka and Y. Terawaki, 1985. Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788. Japanese J. Pharmacol., 37: 101-105.
    CrossRef  |  
  100. Kubota, K., K. Sugaya, I. Matsuda, Y. Matsuoka and M. Itonaga, 1985. Caerulein antagonism by benzodiazepines in the food intake in mice. Japanese J. Pharmacol., 39: 120-122.
    CrossRef  |  
  101. Kubota, K., K. Sugaya, F. Fujii, M. Itonaga and N. Sunagane, 1985. Inhibition of cholecystokinin response in the gallbladder by dibenamine and its protection by benzodiazepines. Japanese J. Pharmacol., 39: 274-276.
    CrossRef  |